Table 1. Baseline characteristics of the participants (ITT population).
| Characteristics | n = 40 | |
|---|---|---|
| Age (y) | 53.4 ± 5.1 | |
| Weight (kg) | 66.8 ± 9.0 | |
| Height (cm) | 162.6 ± 5.4 | |
| BMI (kg/m2) | 25.3 ± 3.5 | |
| Time since menopause (months)a | 55.1 ± 41.2 | |
| Reason for menopause | ||
| Natural process | 37 (92.5) | |
| Oophorectomy | 2 (5.0) | |
| Otherb | 1 (2.5) | |
| Medication in the previous month | 0 (0.0) | |
| Previous clinically relevant comorbidities and/or surgery | 8 (20.0) | |
Data are presented as mean ± SD or number (%).
BMI: body mass index, ITT: intention-to-treat population.
aMonths elapsed between the date of the last menstrual period and the date of informed consent. bSpecification of other reasons for menopause (n = 1; early menopause).